ATMP Supply Chain Product-Centric and Patient-Centric Overview

This white paper examines the challenges of addressing patient-centric and product-centric needs for advanced therapy supply. The supply of three different advanced therapies are reviewed to highlight the challenges of delivering cell therapy drug products efficiently, compliantly and safely in a cost-effective manner.

Written as part of the InnovateUK challenge to prepare UK healthcare infrastructure for ATMPs in collaboration with ATTC and Cell and Gene Therapy Catapult